$HALB "MarketWatch" Features Halberd Corporation W
Post# of 18864
(Total Views: 132)
Posted On: 05/19/2021 8:16:51 AM
$HALB "MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19.
Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with six other notable biotechnology companies. As stated in the article, "The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (PFE), BioNTech SE - ADR (BNTX), Moderna Inc (MRNA), AstraZeneca plc (NAZN), Novavax Inc (NVAX), Halberd Corp (OTC PINK:HALB), and Johnson & Johnson (JNJ)."
The article goes on to recognize Halberd for its innovative approach - using radio waves or laser emissive energy, extracorporeally, to eradicate the SARS-CoV-2 virus from bodily fluids, stating, "The company [Halberd] may be one of the few that has the capacity to offer something materially different to the established paradigm."
William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, "We are proud to be included in this auspicious group of Covid-19 technology leaders. While we do not know whether any of the other companies mentioned in the article paid for their inclusion in it, Halberd Corporation did not. A careful analysis of the article and the relative contributions of each mentioned company reveals that what Halberd has is clearly the most unique and most susceptible to sustainable universal disease treatment, and thus useful beyond Covid-19."
To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/)
For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com;
support@halberdcorporation.com
http://www.halberdcorporation.com
Twitter:@HalberdC
Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with six other notable biotechnology companies. As stated in the article, "The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (PFE), BioNTech SE - ADR (BNTX), Moderna Inc (MRNA), AstraZeneca plc (NAZN), Novavax Inc (NVAX), Halberd Corp (OTC PINK:HALB), and Johnson & Johnson (JNJ)."
The article goes on to recognize Halberd for its innovative approach - using radio waves or laser emissive energy, extracorporeally, to eradicate the SARS-CoV-2 virus from bodily fluids, stating, "The company [Halberd] may be one of the few that has the capacity to offer something materially different to the established paradigm."
William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, "We are proud to be included in this auspicious group of Covid-19 technology leaders. While we do not know whether any of the other companies mentioned in the article paid for their inclusion in it, Halberd Corporation did not. A careful analysis of the article and the relative contributions of each mentioned company reveals that what Halberd has is clearly the most unique and most susceptible to sustainable universal disease treatment, and thus useful beyond Covid-19."
To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/)
For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com;
support@halberdcorporation.com
http://www.halberdcorporation.com
Twitter:@HalberdC
(0)
(0)